Evidence map›Paper›PMID 40936695›Full record

ArticleFrontiers in oncology2025

Two case reports of renal-splenic disease presenting as renal tumors or metastases, with a literature review.

Lijing Xu, Jialin Wang, Guangxi Sun, Hao Zeng

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lijing XuDepartment of Urology, West China Xiamen Hospital, Sichuan University, Xiamen, Fujian, China.
Jialin WangDepartment of Urology, West China Xiamen Hospital, Sichuan University, Xiamen, Fujian, China.
Guangxi SunDepartment of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Hao ZengDepartment of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article provides a comprehensive review of studies and case analyses on ectopic splenic tissue, with a particular focus on renosplenic disease. Ectopic splenic tissue refers to the abnormal non-physiological localization of spleen tissue, commonly resulting from splenic tissue implantation or hematogenous metastasis following splenectomy. Renosplenic disease is rare and often misdiagnosed as a renal tumor or tumor recurrence, which can lead to unnecessary surgical interventions. By discussing two cases of postoperative renosplenic disease in detail and combining them with a literature review, this article explores the pathogenesis, clinical presentation, imaging characteristics, and diagnostic methods of the condition. Analysis of 39 previously reported cases of nephrosplenopathy revealed that it predominantly affects male patients, typically occurs on the left side, and is often associated with a history of splenectomy, with lesions identified on average 20 years post-splenectomy. The clinical manifestations of nephroplenic disease are nonspecific and are mostly incidental findings during imaging examinations. Hybrid SPECT/CT and SPIO-enhanced MRI are considered the gold standards for diagnosing ectopic splenic tissue. However, the majority of cases are still confirmed through needle biopsy or surgical resection. While surgical diagnosis allows for lesion removal, it also carries risks of postoperative complications, such as intestinal fistula, as reported in one of the cases in this study. Research indicates that ectopic splenic tissue is generally benign but can cause symptoms by compressing adjacent structures. For asymptomatic patients, conservative management or active surveillance is a viable approach. However, in cases of large lesions, the decision between conservative treatment and surgical intervention should be carefully weighed. By summarizing 48 years of nephroplenic disease case data, this article aims to provide a clinical reference for the diagnosis and management of the condition. It emphasizes the critical role of imaging examinations and the potential for conservative treatment, aiming to reduce surgical risks and recovery times while improving diagnostic accuracy, treatment outcomes, and patients' quality of life.

Indexed as

diagnostic imagingmetastatic cancerRCC (renal cell carcinoma)renal splenosissurgery

Identifiers

PMID40936695
PMCPMC12420250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.